REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,030,499 | +1940.8% | 7,000 | +2233.3% | 0.08% | +1420.0% |
| Q1 2023 | $246,501 | -78.6% | 300 | -81.2% | 0.01% | -80.8% |
| Q4 2022 | $1,154,384 | -20.2% | 1,600 | -23.8% | 0.03% | -3.7% |
| Q3 2022 | $1,447,000 | +377.6% | 2,100 | +320.0% | 0.03% | +170.0% |
| Q3 2021 | $303,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Garda Capital Partners LP | 3,500 | $2,880,360 | 0.13% |
| GROUP ONE TRADING, L.P. | 31,900 | $26,252,424 | 0.09% |
| SIMPLEX TRADING, LLC | 33,500 | $27,569 | 0.02% |
| IMC-Chicago, LLC | 26,500 | $21,808,440 | 0.02% |
| Allianz Asset Management GmbH | 12,400 | $10,204,704 | 0.02% |
| SG Americas Securities, LLC | 16,700 | $1,142 | 0.01% |
| JANE STREET GROUP, LLC | 42,400 | $34,893,504 | 0.01% |
| JPMORGAN CHASE & CO | 32,900 | $27,075,384 | 0.00% |
| Focused Wealth Management, Inc | 400 | $12,441 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |